Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Fuster

Showing results (261-270 of 512) with videos related to

Pageof 52
Sort By:
Trends in Cardiovascular Medicine|January 18, 2011
Hirudin and other thrombin inhibitors experimental results and potential clinical applicationsL Badimon, A Merino, J Badimon, et al.
Lancet (London, England)|June 19, 1993
Are both aspirin and heparin justified as adjuncts to thrombolytic therapy for acute myocardial infarction?P M Ridker, P R Hebert, V Fuster, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|August 18, 1981
The role of Willebrand factor in platelet - blood vessel interaction, including a discussion of resistance to atherosclerosis in pigs with von Willebrand's diseaseE J Bowie, V Fuster, D N Fass, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 1, 1997
Water diffusion properties of human atherosclerosis and thrombosis measured by pulse field gradient nuclear magnetic resonanceJ F Toussaint, J F Southern, V Fuster, et al.
Thrombosis Et Diathesis Haemorrhagica|November 25, 1975
Proceedings: Resistance to the development of spontaneous atherosclerosis in pigs with von Willebrand's diseaseE J Bowie, V Fuster, C A Owen, et al.
Journal of the American College of Cardiology|October 16, 1999
AHA/ACC scientific statement: Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of CardiologyS M Grundy, R Pasternak, P Greenland, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 1, 1989
High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbitsJ J Badimon, L Badimon, A Galvez, et al.
British Heart Journal|April 1, 1981
Coronary artery thrombosis in patients with unstable anginaD R Holmes, G O Hartzler, H C Smith, et al.
Journal of Biosocial Science|August 10, 2012
Genetics of population exchange along the historical Portuguese-Spanish borderJ Román-Busto, M Tasso, G Caravello, et al.
Journal of the American College of Cardiology|April 1, 1996
27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 1. Pathogenesis of coronary disease: the biologic role of risk factorsV Fuster, A M Gotto, P Libby, et al.
Pageof 52

Showing results (261-270 of 512) with videos related to

Sort By:
Pageof 52
Trends in Cardiovascular Medicine|January 18, 2011
Hirudin and other thrombin inhibitors experimental results and potential clinical applicationsL Badimon, A Merino, J Badimon, et al.
Lancet (London, England)|June 19, 1993
Are both aspirin and heparin justified as adjuncts to thrombolytic therapy for acute myocardial infarction?P M Ridker, P R Hebert, V Fuster, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|August 18, 1981
The role of Willebrand factor in platelet - blood vessel interaction, including a discussion of resistance to atherosclerosis in pigs with von Willebrand's diseaseE J Bowie, V Fuster, D N Fass, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 1, 1997
Water diffusion properties of human atherosclerosis and thrombosis measured by pulse field gradient nuclear magnetic resonanceJ F Toussaint, J F Southern, V Fuster, et al.
Thrombosis Et Diathesis Haemorrhagica|November 25, 1975
Proceedings: Resistance to the development of spontaneous atherosclerosis in pigs with von Willebrand's diseaseE J Bowie, V Fuster, C A Owen, et al.
Journal of the American College of Cardiology|October 16, 1999
AHA/ACC scientific statement: Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of CardiologyS M Grundy, R Pasternak, P Greenland, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 1, 1989
High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbitsJ J Badimon, L Badimon, A Galvez, et al.
British Heart Journal|April 1, 1981
Coronary artery thrombosis in patients with unstable anginaD R Holmes, G O Hartzler, H C Smith, et al.
Journal of Biosocial Science|August 10, 2012
Genetics of population exchange along the historical Portuguese-Spanish borderJ Román-Busto, M Tasso, G Caravello, et al.
Journal of the American College of Cardiology|April 1, 1996
27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 1. Pathogenesis of coronary disease: the biologic role of risk factorsV Fuster, A M Gotto, P Libby, et al.
Pageof 52